Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies.

Cenciarini M, Valentino M, Belia S, Sforna L, Rosa P, Ronchetti S, D'Adamo MC, Pessia M.

Front Mol Neurosci. 2019 Mar 29;12:65. doi: 10.3389/fnmol.2019.00065. eCollection 2019. Review.

2.

Identification of a New de Novo Mutation Underlying Regressive Episodic Ataxia Type I.

Karalok ZS, Megaro A, Cenciarini M, Guven A, Hasan SM, Taskin BD, Imbrici P, Ceylaner S, Pessia M, D'Adamo MC.

Front Neurol. 2018 Jul 25;9:587. doi: 10.3389/fneur.2018.00587. eCollection 2018.

3.

Commentary: A channelopathy mutation in the voltage-sensor discloses contributions of a conserved phenylalanine to gating properties of Kv1.1 channels and ataxia.

Hasan S, Hunter T, Hunter G, Pessia M, D'Adamo MC.

Front Cell Neurosci. 2018 Jun 20;12:174. doi: 10.3389/fncel.2018.00174. eCollection 2018. No abstract available.

4.

Reply to 'F508del-CFTR is not corrected by thymosin α1'.

Romani L, Stincardini C, Giovagnoli S, Paci M, Villella VR, Sforna L, Renga G, Bellet MM, Costantini C, Puccetti P, Kroemer G, Maiuri L, Pessia M, Goldstein A, Garaci E.

Nat Med. 2018 Jul;24(7):891-893. doi: 10.1038/s41591-018-0080-0. No abstract available.

PMID:
29942090
5.

Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.

Romani L, Oikonomou V, Moretti S, Iannitti RG, D'Adamo MC, Villella VR, Pariano M, Sforna L, Borghi M, Bellet MM, Fallarino F, Pallotta MT, Servillo G, Ferrari E, Puccetti P, Kroemer G, Pessia M, Maiuri L, Goldstein AL, Garaci E.

Nat Med. 2018 Sep;24(9):1482. doi: 10.1038/s41591-018-0099-2.

PMID:
29934535
6.

Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.

Romani L, Oikonomou V, Moretti S, Iannitti RG, D'Adamo MC, Villella VR, Pariano M, Sforna L, Borghi M, Bellet MM, Fallarino F, Pallotta MT, Servillo G, Ferrari E, Puccetti P, Kroemer G, Pessia M, Maiuri L, Goldstein AL, Garaci E.

Nat Med. 2018 Sep;24(9):1481. doi: 10.1038/s41591-018-0100-0.

PMID:
29934534
7.

Structure, Gating and Basic Functions of the Ca2+-activated K Channel of Intermediate Conductance.

Sforna L, Megaro A, Pessia M, Franciolini F, Catacuzzeno L.

Curr Neuropharmacol. 2018;16(5):608-617. doi: 10.2174/1570159X15666170830122402. Review.

8.

Lethal digenic mutations in the K+ channels Kir4.1 (KCNJ10) and SLACK (KCNT1) associated with severe-disabling seizures and neurodevelopmental delay.

Hasan S, Balobaid A, Grottesi A, Dabbagh O, Cenciarini M, Rawashdeh R, Al-Sagheir A, Bove C, Macchioni L, Pessia M, Al-Owain M, D'Adamo MC.

J Neurophysiol. 2017 Oct 1;118(4):2402-2411. doi: 10.1152/jn.00284.2017. Epub 2017 Jul 26.

9.

A channelopathy mutation in the voltage-sensor discloses contributions of a conserved phenylalanine to gating properties of Kv1.1 channels and ataxia.

Hasan S, Bove C, Silvestri G, Mantuano E, Modoni A, Veneziano L, Macchioni L, Hunter T, Hunter G, Pessia M, D'Adamo MC.

Sci Rep. 2017 Jul 4;7(1):4583. doi: 10.1038/s41598-017-03041-z.

10.

A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions.

Imbrici P, Altamura C, Gualandi F, Mangiatordi GF, Neri M, De Maria G, Ferlini A, Padovani A, D'Adamo MC, Nicolotti O, Pessia M, Conte D, Filosto M, Desaphy JF.

Mol Cell Neurosci. 2017 Sep;83:6-12. doi: 10.1016/j.mcn.2017.06.006. Epub 2017 Jun 28.

PMID:
28666963
11.

Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.

Romani L, Oikonomou V, Moretti S, Iannitti RG, D'Adamo MC, Villella VR, Pariano M, Sforna L, Borghi M, Bellet MM, Fallarino F, Pallotta MT, Servillo G, Ferrari E, Puccetti P, Kroemer G, Pessia M, Maiuri L, Goldstein AL, Garaci E.

Nat Med. 2017 May;23(5):590-600. doi: 10.1038/nm.4305. Epub 2017 Apr 10. Erratum in: Nat Med. 2018 Sep;24(9):1481. Nat Med. 2018 Sep;24(9):1482.

12.

Gain-of-function defects of astrocytic Kir4.1 channels in children with autism spectrum disorders and epilepsy.

Sicca F, Ambrosini E, Marchese M, Sforna L, Servettini I, Valvo G, Brignone MS, Lanciotti A, Moro F, Grottesi A, Catacuzzeno L, Baldini S, Hasan S, D'Adamo MC, Franciolini F, Molinari P, Santorelli FM, Pessia M.

Sci Rep. 2016 Sep 28;6:34325. doi: 10.1038/srep34325.

13.

Overexpression of Large-Conductance Calcium-Activated Potassium Channels in Human Glioblastoma Stem-Like Cells and Their Role in Cell Migration.

Rosa P, Sforna L, Carlomagno S, Mangino G, Miscusi M, Pessia M, Franciolini F, Calogero A, Catacuzzeno L.

J Cell Physiol. 2017 Sep;232(9):2478-2488. doi: 10.1002/jcp.25592. Epub 2017 Apr 10.

PMID:
27606467
14.

KCNA4 deficiency leads to a syndrome of abnormal striatum, congenital cataract and intellectual disability.

Kaya N, Alsagob M, D'Adamo MC, Al-Bakheet A, Hasan S, Muccioli M, Almutairi FB, Almass R, Aldosary M, Monies D, Mustafa OM, Alyounes B, Kenana R, Al-Zahrani J, Naim E, Binhumaid FS, Qari A, Almutairi F, Meyer B, Plageman TF, Pessia M, Colak D, Al-Owain M.

J Med Genet. 2016 Nov;53(11):786-792. doi: 10.1136/jmedgenet-2015-103637. Epub 2016 Aug 31.

PMID:
27582084
15.

A Calsequestrin-1 Mutation Associated with a Skeletal Muscle Disease Alters Sarcoplasmic Ca2+ Release.

D'Adamo MC, Sforna L, Visentin S, Grottesi A, Servettini L, Guglielmi L, Macchioni L, Saredi S, Curcio M, De Nuccio C, Hasan S, Corazzi L, Franciolini F, Mora M, Catacuzzeno L, Pessia M.

PLoS One. 2016 May 19;11(5):e0155516. doi: 10.1371/journal.pone.0155516. eCollection 2016.

16.

Hypoxia Modulates the Swelling-Activated Cl Current in Human Glioblastoma Cells: Role in Volume Regulation and Cell Survival.

Sforna L, Cenciarini M, Belia S, Michelucci A, Pessia M, Franciolini F, Catacuzzeno L.

J Cell Physiol. 2017 Jan;232(1):91-100. doi: 10.1002/jcp.25393. Epub 2016 Aug 26.

PMID:
27028592
17.

Megalencephalic leukoencephalopathy with subcortical cysts protein-1 regulates epidermal growth factor receptor signaling in astrocytes.

Lanciotti A, Brignone MS, Visentin S, De Nuccio C, Catacuzzeno L, Mallozzi C, Petrini S, Caramia M, Veroni C, Minnone G, Bernardo A, Franciolini F, Pessia M, Bertini E, Petrucci TC, Ambrosini E.

Hum Mol Genet. 2016 Apr 15;25(8):1543-58. doi: 10.1093/hmg/ddw032. Epub 2016 Feb 9.

PMID:
26908604
18.

A CASQ1 founder mutation in three Italian families with protein aggregate myopathy and hyperCKaemia.

Di Blasi C, Sansanelli S, Ruggieri A, Moriggi M, Vasso M, D'Adamo AP, Blasevich F, Zanotti S, Paolini C, Protasi F, Tezzon F, Gelfi C, Morandi L, Pessia M, Mora M.

J Med Genet. 2015 Sep;52(9):617-26. doi: 10.1136/jmedgenet-2014-102882. Epub 2015 Jul 1.

PMID:
26136523
19.

De novo point mutations in patients diagnosed with ataxic cerebral palsy.

Parolin Schnekenberg R, Perkins EM, Miller JW, Davies WI, D'Adamo MC, Pessia M, Fawcett KA, Sims D, Gillard E, Hudspith K, Skehel P, Williams J, O'Regan M, Jayawant S, Jefferson R, Hughes S, Lustenberger A, Ragoussis J, Jackson M, Tucker SJ, Németh AH.

Brain. 2015 Jul;138(Pt 7):1817-32. doi: 10.1093/brain/awv117. Epub 2015 May 16. Erratum in: Brain. 2016 Feb;139(Pt 2):e14.

20.

ClC-1 chloride channels: state-of-the-art research and future challenges.

Imbrici P, Altamura C, Pessia M, Mantegazza R, Desaphy JF, Camerino DC.

Front Cell Neurosci. 2015 Apr 27;9:156. doi: 10.3389/fncel.2015.00156. eCollection 2015. Review.

21.

Reconciling the discrepancies on the involvement of large-conductance Ca(2+)-activated K channels in glioblastoma cell migration.

Catacuzzeno L, Caramia M, Sforna L, Belia S, Guglielmi L, D'Adamo MC, Pessia M, Franciolini F.

Front Cell Neurosci. 2015 Apr 20;9:152. doi: 10.3389/fncel.2015.00152. eCollection 2015. Review.

22.

Update on the implication of potassium channels in autism: K(+) channelautism spectrum disorder.

Guglielmi L, Servettini I, Caramia M, Catacuzzeno L, Franciolini F, D'Adamo MC, Pessia M.

Front Cell Neurosci. 2015 Mar 2;9:34. doi: 10.3389/fncel.2015.00034. eCollection 2015. Review.

23.

Expression and function of a CP339,818-sensitive K⁺ current in a subpopulation of putative nociceptive neurons from adult mouse trigeminal ganglia.

Sforna L, D'Adamo MC, Servettini I, Guglielmi L, Pessia M, Franciolini F, Catacuzzeno L.

J Neurophysiol. 2015 Apr 1;113(7):2653-65. doi: 10.1152/jn.00379.2014. Epub 2015 Feb 4.

24.

Novel phenotype associated with a mutation in the KCNA1(Kv1.1) gene.

D'Adamo MC, Gallenmüller C, Servettini I, Hartl E, Tucker SJ, Arning L, Biskup S, Grottesi A, Guglielmi L, Imbrici P, Bernasconi P, Di Giovanni G, Franciolini F, Catacuzzeno L, Pessia M, Klopstock T.

Front Physiol. 2015 Jan 15;5:525. doi: 10.3389/fphys.2014.00525. eCollection 2014.

25.

The role of ion channels in the hypoxia-induced aggressiveness of glioblastoma.

Sforna L, Cenciarini M, Belia S, D'Adamo MC, Pessia M, Franciolini F, Catacuzzeno L.

Front Cell Neurosci. 2015 Jan 15;8:467. doi: 10.3389/fncel.2014.00467. eCollection 2014.

26.

Role(s) of the 5-HT2C receptor in the development of maximal dentate activation in the hippocampus of anesthetized rats.

Orban G, Bombardi C, Marino Gammazza A, Colangeli R, Pierucci M, Pomara C, Pessia M, Bucchieri F, Benigno A, Smolders I, De Deurwaerdère P, Di Giovanni G.

CNS Neurosci Ther. 2014 Jul;20(7):651-61. doi: 10.1111/cns.12285. Erratum in: CNS Neurosci Ther. 2014 Oct;20(10):950. Arcangelo, Benigno [corrected to Benigno, Arcangelo].

27.

Genetically induced dysfunctions of Kir2.1 channels: implications for short QT3 syndrome and autism-epilepsy phenotype.

Ambrosini E, Sicca F, Brignone MS, D'Adamo MC, Napolitano C, Servettini I, Moro F, Ruan Y, Guglielmi L, Pieroni S, Servillo G, Lanciotti A, Valvo G, Catacuzzeno L, Franciolini F, Molinari P, Marchese M, Grottesi A, Guerrini R, Santorelli FM, Priori S, Pessia M.

Hum Mol Genet. 2014 Sep 15;23(18):4875-86. doi: 10.1093/hmg/ddu201. Epub 2014 May 2.

28.

A method to identify tissue cell subpopulations with distinct multi-molecular profiles from data on co-localization of two markers at a time: the case of sensory ganglia.

Catacuzzeno L, Sforna L, D'Adamo MC, Pessia M, Franciolini F.

J Neurosci Methods. 2014 Mar 15;224:88-95. doi: 10.1016/j.jneumeth.2013.12.015. Epub 2014 Jan 8.

PMID:
24412313
29.

K(+) channelepsy: progress in the neurobiology of potassium channels and epilepsy.

D'Adamo MC, Catacuzzeno L, Di Giovanni G, Franciolini F, Pessia M.

Front Cell Neurosci. 2013 Sep 13;7:134. doi: 10.3389/fncel.2013.00134. Erratum in: Front Cell Neurosci. 2014;8:9.

30.

High dose of 8-OH-DPAT decreases maximal dentate gyrus activation and facilitates granular cell plasticity in vivo.

Orban G, Pierucci M, Benigno A, Pessia M, Galati S, Valentino M, Muscat R, Di Giovanni G.

Exp Brain Res. 2013 Oct;230(4):441-51. doi: 10.1007/s00221-013-3594-1. Epub 2013 Jun 19.

PMID:
23780309
31.

A large cohort of myotonia congenita probands: novel mutations and a high-frequency mutation region in exons 4 and 5 of the CLCN1 gene.

Brugnoni R, Kapetis D, Imbrici P, Pessia M, Canioni E, Colleoni L, de Rosbo NK, Morandi L, Cudia P, Gashemi N, Bernasconi P, Desaphy JF, Conte D, Mantegazza R.

J Hum Genet. 2013 Sep;58(9):581-7. doi: 10.1038/jhg.2013.58. Epub 2013 Jun 6.

PMID:
23739125
32.

5-HT2 receptors-mediated modulation of voltage-gated K+ channels and neurophysiopathological correlates.

D'Adamo MC, Servettini I, Guglielmi L, Di Matteo V, Di Maio R, Di Giovanni G, Pessia M.

Exp Brain Res. 2013 Oct;230(4):453-62. doi: 10.1007/s00221-013-3555-8. Epub 2013 May 24. Review.

PMID:
23702970
33.

The role of the serotonergic system at the interface of aggression and suicide.

Bortolato M, Pivac N, Muck Seler D, Nikolac Perkovic M, Pessia M, Di Giovanni G.

Neuroscience. 2013 Apr 16;236:160-85. doi: 10.1016/j.neuroscience.2013.01.015. Epub 2013 Jan 16. Review.

34.

Kv1.1 knock-in ataxic mice exhibit spontaneous myokymic activity exacerbated by fatigue, ischemia and low temperature.

Brunetti O, Imbrici P, Botti FM, Pettorossi VE, D'Adamo MC, Valentino M, Zammit C, Mora M, Gibertini S, Di Giovanni G, Muscat R, Pessia M.

Neurobiol Dis. 2012 Sep;47(3):310-21. doi: 10.1016/j.nbd.2012.05.002. Epub 2012 May 17.

35.

Redox sensitivity of tyrosine hydroxylase activity and expression in dopaminergic dysfunction.

Di Giovanni G, Pessia M, Di Maio R.

CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):419-29. Review.

PMID:
22483306
36.

Autism with seizures and intellectual disability: possible causative role of gain-of-function of the inwardly-rectifying K+ channel Kir4.1.

Sicca F, Imbrici P, D'Adamo MC, Moro F, Bonatti F, Brovedani P, Grottesi A, Guerrini R, Masi G, Santorelli FM, Pessia M.

Neurobiol Dis. 2011 Jul;43(1):239-47. doi: 10.1016/j.nbd.2011.03.016. Epub 2011 Mar 31.

PMID:
21458570
37.

Episodic ataxia type 1 mutations affect fast inactivation of K+ channels by a reduction in either subunit surface expression or affinity for inactivation domain.

Imbrici P, D'Adamo MC, Grottesi A, Biscarini A, Pessia M.

Am J Physiol Cell Physiol. 2011 Jun;300(6):C1314-22. doi: 10.1152/ajpcell.00456.2010. Epub 2011 Feb 9.

38.

Genetic inactivation of Kcnj16 identifies Kir5.1 as an important determinant of neuronal PCO2/pH sensitivity.

D'Adamo MC, Shang L, Imbrici P, Brown SD, Pessia M, Tucker SJ.

J Biol Chem. 2011 Jan 7;286(1):192-8. doi: 10.1074/jbc.M110.189290. Epub 2010 Nov 3.

39.

Trace amines depress D(2)-autoreceptor-mediated responses on midbrain dopaminergic cells.

Ledonne A, Federici M, Giustizieri M, Pessia M, Imbrici P, Millan MJ, Bernardi G, Mercuri NB.

Br J Pharmacol. 2010 Jul;160(6):1509-20. doi: 10.1111/j.1476-5381.2010.00792.x.

40.

Contribution of the central hydrophobic residue in the PXP motif of voltage-dependent K+ channels to S6 flexibility and gating properties.

Imbrici P, Grottesi A, D'Adamo MC, Mannucci R, Tucker SJ, Pessia M.

Channels (Austin). 2009 Jan-Feb;3(1):39-45. Epub 2009 Jan 3.

PMID:
19202350
41.

A novel KCNA1 mutation identified in an Italian family affected by episodic ataxia type 1.

Imbrici P, Gualandi F, D'Adamo MC, Masieri MT, Cudia P, De Grandis D, Mannucci R, Nicoletti I, Tucker SJ, Ferlini A, Pessia M.

Neuroscience. 2008 Dec 2;157(3):577-87. doi: 10.1016/j.neuroscience.2008.09.022. Epub 2008 Sep 24.

PMID:
18926884
42.

ERG voltage-gated K+ channels regulate excitability and discharge dynamics of the medial vestibular nucleus neurones.

Pessia M, Servettini I, Panichi R, Guasti L, Grassi S, Arcangeli A, Wanke E, Pettorossi VE.

J Physiol. 2008 Oct 15;586(20):4877-90. doi: 10.1113/jphysiol.2008.155762. Epub 2008 Aug 21.

43.
44.

Episodic ataxia type 1 mutation F184C alters Zn2+-induced modulation of the human K+ channel Kv1.4-Kv1.1/Kvbeta1.1.

Imbrici P, D'Adamo MC, Cusimano A, Pessia M.

Am J Physiol Cell Physiol. 2007 Feb;292(2):C778-87. Epub 2006 Sep 6.

45.
46.

Identification of a heteromeric interaction that influences the rectification, gating, and pH sensitivity of Kir4.1/Kir5.1 potassium channels.

Casamassima M, D'Adamo MC, Pessia M, Tucker SJ.

J Biol Chem. 2003 Oct 31;278(44):43533-40. Epub 2003 Aug 15.

47.

Functional characterization of an episodic ataxia type-1 mutation occurring in the S1 segment of hKv1.1 channels.

Imbrici P, Cusimano A, D'Adamo MC, De Curtis A, Pessia M.

Pflugers Arch. 2003 Jun;446(3):373-9. Epub 2002 Nov 26.

PMID:
12799903
48.

Exogenous glutamate induces short and long-term potentiation in the rat medial vestibular nuclei.

Grassi S, Frondaroli A, Pessia M, Pettorossi VE.

Neuroreport. 2001 Aug 8;12(11):2329-34.

PMID:
11496105
49.

Differential pH sensitivity of Kir4.1 and Kir4.2 potassium channels and their modulation by heteropolymerisation with Kir5.1.

Pessia M, Imbrici P, D'Adamo MC, Salvatore L, Tucker SJ.

J Physiol. 2001 Apr 15;532(Pt 2):359-67.

50.

Supplemental Content

Loading ...
Support Center